Literature DB >> 9145900

Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.

E J Goldstein1, D M Citron, S Hunt Gerardo, M Hudspeth, C V Merriam.   

Abstract

The activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against bite wound isolates were determined by the agar dilution method. DU-6859a was the most active compound (MICs, < or = 0.125 microg/ml) against all Pasteurella species, Staphylococcus aureus, and streptococci; anaerobes were susceptible to < or = 0.5 microg/ml, except fusobacteria, which were susceptible to < or = 2 microg/ml. Against aerobes, levofloxacin was more active than ofloxacin (MIC at which 90% of isolates are inhibited [MIC90], < or = 1.0 microg/ml for both) and sparfloxacin and ciprofloxacin were also active (MIC90s, < or = 0.25 and < 1 microg/ml, respectively).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145900      PMCID: PMC163881     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

2.  The in-vitro activity of a new highly active quinolone, DU-6859a.

Authors:  A Jolley; J M Andrews; N Brenwald; R Wise
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

3.  In vitro activity of S-ofloxacin.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans.

Authors:  C J Alexander; D M Citron; S Hunt Gerardo; M C Claros; D Talan; E J Goldstein
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

6.  Characterization and distribution of Pasteurella species recovered from infected humans.

Authors:  E Holst; J Rollof; L Larsson; J P Nielsen
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  In vitro activity of DU-6859a against anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; D Reeves; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

  7 in total
  4 in total

1.  Postoperative care of the facial laceration.

Authors:  Nicholas Medel; Neeraj Panchal; Edward Ellis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-12

Review 2.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.

Authors:  Gabriel Marcelín-Jiménez; Alionka P Angeles; Luis Martínez-Rossier; Adolfo Fernández S
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 4.  Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.

Authors:  H D Langtry; H M Lamb
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.